Mereo BioPharma Group plc announced, effective August 1, 2020, current Mereo Board of Directors member Mr. Michael Wyzga became Interim Chief Financial Officer. As a result of Wyzga’s appointment to Interim Chief Financial Officer, Mr. Wyzga’s membership of the Audit and Risk Committee of the board will cease until a new Chief Financial Officer has been hired, though Mr. Wyzga will remain as an executive director of the board.